Danli Zhou
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 2
- Oncology 5
- CAR-T cell therapy research 3
- Co-authors
- Zhengying Pan (4 shared papers)Gang Xue (3 shared papers)Kun Wang (1 shared paper)Hanbing Zhong (1 shared paper)Yingying Zuo (3 shared papers)Xiao‐Hong Wei (2 shared papers)Bing Zhou (1 shared paper)Jie Xu (1 shared paper)
In The Last Decade
Danli Zhou
12 papers receiving 567 citations
Peers
Comparison fields: 5 of 70
- Hematology 106
- Oncology 163
- Molecular Biology 412
- Complementary and alternative medicine 19
- Neurology 19
Countries citing papers authored by Danli Zhou
This map shows the geographic impact of Danli Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danli Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danli Zhou more than expected).
Fields of papers citing papers by Danli Zhou
This network shows the impact of papers produced by Danli Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danli Zhou. The network helps show where Danli Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Danli Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 279 | |
| 2 | 2020 | 85 | |
| 3 | 2017 | 72 | |
| 4 | 2019 | 65 | |
| 5 | 2014 | 27 | |
| 6 | 2023 | 17 | |
| 7 | 2021 | 8 | |
| 8 | 2018 | 7 | |
| 9 | 2015 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 0 | |
| 14 | 2024 | 0 | |
| 15 | Effects of Continuous Nutritional Intervention on Nutritional Status and Serum Albumin During Maintenance Therapy in Children with Acute Lymphoblastic Leukemia. | 2024 | 0 |
| 16 | 2025 | 0 |
About Danli Zhou
Danli Zhou is a scholar working on Molecular Biology, Oncology, Genetics, Cell Biology and Physiology, having authored 16 papers that have together received 573 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), CAR-T cell therapy research (3 papers), Ubiquitin and proteasome pathways (2 papers), Pain Mechanisms and Treatments (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Moyamoya disease diagnosis and treatment (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper) and Gout, Hyperuricemia, Uric Acid (1 paper). The work is most often cited by research in Hematology (106 citations), Oncology (163 citations), Molecular Biology (412 citations), Complementary and alternative medicine (19 citations) and Neurology (19 citations). Danli Zhou has collaborated with scholars based in China, Italy and Singapore. Frequent co-authors include Zhengying Pan, Gang Xue, Kun Wang, Hanbing Zhong, Yingying Zuo, Xiao‐Hong Wei, Bing Zhou, Jie Xu, Jiahui Chen and Siqi Zhang. Their work appears in journals such as Chemical Communications, Pharmacogenetics and Genomics, Environmental Pollution, Acta Pharmacologica Sinica and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.